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Abstract
The genus Anaplasma (Rickettsiales: Anaplasmataceae) includes several pathogens of veterinary and
human medical importance. An understanding of the diversity of Anaplasma major surface proteins
(MSPs), including those MSPs that modulate infection, development of persistent infections, and
transmission of pathogens by ticks, is derived in part, by characterization and phylogenetic analyses of
geographic strains. Information concerning the genetic diversity of Anaplasma spp. MSPs will likely
influence the development of serodiagnostic assays and vaccine strategies for the control of
anaplasmosis.
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Abstract
The genus Anaplasma (Rickettsiales: Anaplasmataceae) includes several pathogens of
veterinary and human medical importance. An understanding of the diversity of Anaplasma
major surface proteins (MSPs), including those MSPs that modulate infection, development
of persistent infections, and transmission of pathogens by ticks, is derived in part, by
characterization and phylogenetic analyses of geographic strains. Information concerning the
genetic diversity of Anaplasma spp. MSPs will likely influence the development of
serodiagnostic assays and vaccine strategies for the control of anaplasmosis.
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Introduction
The genus Anaplasma (Rickettsiales: Anaplasmataceae)
contains obligate intracellular organisms found exclu-
sively within membrane-bound vacuoles in the cytoplasm
of both vertebrate and invertebrate host cells (Dumler
et al., 2001). The genus Anaplasma includes pathogens of
ruminants, A. marginale, A. centrale (A. marginale ssp.
centrale), A. bovis (formerly Ehrlichia bovis), and A. ovis.
Also included in this genus is A. phagocytophilum
(previously recognized as E. equi, E. phagocytophila, and
the human granulocytic ehrlichiosis (HGE) agent), which
infects a wide range of hosts including humans, rodents,
birds, dogs and cattle, and A. platys (formerly E. platys)
which infects dogs. Aegyptianella, which is infective for
birds, was originally retained as a genus incertae sedis due
to lack of sequence information, but was recently
confirmed to be closely related to Anaplasma spp., based
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on 16 S rRNA and groEL gene sequences of Ae. pullorum
(Rikihisa et al., 2003). However, Aegyptianella has yet to
be formally renamed as a member of the Anaplasma
genus.
The type species for the genus Anaplasma, A. margi-
nale, is an obligate intraerythrocytic pathogen that causes
bovine anaplasmosis (reviewed by Kocan et al., 2003).
Anaplasmosis is endemic in tropical and sub-tropical
regions of the world and the disease causes considerable
economic losses globally to both dairy and beef industries
worldwide (reviewed by Kocan et al., 2003). Biological
transmission of A. marginale is effected by ticks and
approximately 20 species of ticks have been incriminated
as vectors worldwide, while mechanical transmission
occurs when infected blood is transferred to susceptible
cattle by biting flies or blood-contaminated fomites
(reviewed by Kocan et al., 2004). Many geographic
strains of A. marginale have been identified that differ
in biology, morphology, protein sequences, antigenic
characteristics, and infectivity for ticks (reviewed by de la
Fuente et al., 2001a; Kocan et al., 2003, 2004). Bovine
anaplasmosis often results in the development of mild to
severe anemia and icterus without hemoglobinemia and
hemoglobinuria. Clinical symptoms may include fever,
weight loss, abortion, lethargy, icterus, and often death in
animals over 2-year old (reviewed by Kocan et al., 2003,
2004). Cattle that survive acute infection develop persis-
tent infections characterized by cyclic low-level rickett-
semia (Kieser et al., 1990). Persistently infected or carrier
cattle serve as reservoirs of A. marginale and provide a
source of infective blood for both mechanical transmis-
sion and biological transmission by ticks.
Anaplasma centrale is less pathogenic for cattle than
A. marginale, is only occasionally associated with clinical
disease, and is presently used as a live vaccine in Israel,
Australia, Africa, and South America (reviewed by Bock
et al., 2003). A. ovis, a pathogen of wild and domestic
sheep, does not establish persistent infection or cause
disease in cattle (reviewed by Kocan et al., 2003).
Anaplasma phagocytophilum causes human granulo-
cytic anaplasmosis (HGA), tick-borne fever of ruminants,
and equine and canine granulocytic anaplasmosis
(Dumler et al., 2001). HGA was first described in the
United States in 1994 and subsequently reported in
Europe and South and North America. Since this time,
A. phagocytophilum had become a predominant form of
anaplasmosis and among the most common tick-borne
pathogens in the United States and Europe (Massung and
Slater, 2003; Parola, 2004). Human anaplasmosis is
characterized by fever, headache, myalgia, and malaise,
as well as leukopenia, thrombocytopenia, and elevated
levels of C-reactive protein and liver transaminases, both
of which are evidence of hepatic injury (reviewed by
Carlyon and Fikrig, 2003). Although the disease is usually
self-limiting, severe complications can result, including
prolonged fever, shock, seizures, pneumonitis, acute
renal failure, hemorrhage, rhabdomyolysis, and
opportunistic infections that may result in death
(reviewed by Carlyon and Fikrig, 2003).
Anaplasma phagocytophilum is transmitted by tick
species belonging to the Ixodes persulcatus complex,
including I. scapularis and I. pacificus in the United
States, I. ricinus in Western Europe, and I. persulcatus in
eastern Europe and Asia, but other tick species may
subsequently prove to be vectors (de la Fuente et al.,
2004a). A. phagocytophilum infections are maintained in
nature, at least in part, in small- and medium-sized
mammals including white-footed mice (Peromyscus
leucopus), raccoons (Procyon lotor), and gray squirrels
(Sciurus carolinensis) (Telford et al., 1996; Levin et al.,
2002; Petrovec et al., 2002). Wild rabbits, birds, and
cats have been also implicated in the epidemiology of
A. phagocytophilum (Daniels et al., 2002; Goethert and
Telford, 2003; Lappin et al., 2004). Evidence suggests that
subclinical persistent infections occur in domestic and
wild ruminants, including white-tailed, red, and roe deer
(Dumler et al., 2001; de la Fuente et al., 2004b; Polin et al.,
2004). The clinical and host diversity of A. phagocyto-
philum suggest the presence of genetic differences
among these strains that have not been characterized
and may contribute to the diversity of complex infection–
transmission networks that impact the epidemiology of
the disease.
Recent reports have demonstrated concurrent infec-
tions of Anaplasma spp. in ruminants and ticks (de la
Fuente et al., 2004a; Hofmann-Lehmann et al., 2004; Lin
et al., 2004). The establishment of concurrent Anaplasma
spp. infections in reservoir hosts is likely to increase the
risk of pathogen transmission among wildlife, domestic
animals, and humans, and emphasizes the need for
effective diagnostic assays and vaccines for the control of
anaplasmosis.
Several MSPs have been identified in Anaplasma spp.,
which have been most extensively characterized in
A. marginale (Palmer et al., 1985; reviewed by de la
Fuente et al., 2001a; Kocan et al., 2003, 2004). Some of
these MSPs have been tested for use in serodiagnostic
assays and vaccines. Sequence information that allows
assessment of genetic diversity among Anaplasma strains
have been obtained thus far for MSP1a, MSP2, MSP4, and
MSP5 and therefore this review will focus on genetic
diversity of Anaplasma spp. using these MSPs (Table 1).
The implications of the results of these sequence analyses
for the diagnosis and control of anaplasmosis will be
discussed.
Anaplasma major surface proteins
MSP1a
The gene msp1a, encoding for MSP1a, has only been
identified thus far in A. marginale despite attempts
to clone this gene from A. centrale, A. ovis, and
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A. phagocytophilum (Lew et al., 2002; unpublished
results). MSP1a is one of the six MSPs that have been
identified in A. marginale from bovine erythrocytes and
found to be conserved on A. marginale derived from ticks
and cultured tick cells (reviewed by Kocan et al., 2003,
2004). MSP1a is a part of the MSP1 complex composed of
a heterodimer of two structurally unrelated polypeptides:
MSP1a, which is encoded by a single gene and MSP1b,
which is encoded by at least two genes, msp1b1 and
msp1b2 (Barbet et al., 1987; Viseshakul et al., 2000;
Camacho-Nuez et al., 2000; Bowie et al., 2002). The
MSP1a of A. marginale geographic strains differs in
molecular weight because of a variable number of
tandem 28 or 29 amino acid repeats, and has been used
for strain identification (Allred et al., 1990; de la Fuente
et al., 2001a, 2003a). Within a strain, msp1a does not vary
and has proved to be a stable genetic marker of the
rickettsia through its developmental cycle in cattle and
ticks (Bowie et al., 2002).
MSP1a was shown to be an adhesin for bovine
erythrocytes and both native and cultured tick cells in
microtitre hemagglutination and adhesion assays using
recombinant Escherichia coli expressing MSP1a (McGarey
and Allred, 1994; McGarey et al., 1994; de la Fuente
et al., 2001b), and by light and electron microscopy
(de la Fuente et al., 2001b). MSP1a was also shown to
be involved in the infectivity of A. marginale strains
for Dermacentor spp. (de la Fuente et al., 2001c).
Expression of MSP1a was found to be down-regulated
in tick cells, as compared with organisms derived from
bovine erythrocytes. In addition, both native and recom-
binant MSP1a were found to be glycosylated, a feature
of the repeated N-terminal peptides which appears
to contribute to the adhesive properties and thus
the function of the protein (Garcia-Garcia et al.,
2004a, b, c).
The adhesion domain of MSP1a was identified on the
extracellular N-terminal region of MSP1a that contains the
repeated peptides (de la Fuente et al., 2003b). We
demonstrated by the use of mutant proteins that the
repeated peptides of MSP1a were necessary and sufficient
to mediate adhesion of recombinant MSP1a to tick cells
and bovine erythrocytes, a prerequisite to infection of
host cells (de la Fuente et al., 2003b). The adhesive
capacity of individual peptides for tick cell extract (TCE)
was then evaluated using synthetic peptides representing
the predominant repeated sequences (de la Fuente et al.,
2003b) and was found to be associated with specific
amino acids. Peptides containing acidic amino acids D or
E at position 20 bound to TCE, while peptides with a G as
the 20th amino acid were not adhesive to TCE. Antibodies
produced in rabbits against a synthetic repeated peptide
significantly reduced A. marginale infection of cultured
tick cells, and the neutralization observed was similar to
that obtained using antibodies produced against the
whole MSP1a recombinant protein (de la Fuente et al.,
2003b). Analyses of the tandemly repeated MSP1a
peptides of several geographic strains of A. marginale
revealed a complex relationship between the msp1a
genotype and the tick-transmissible phenotype of the
strain and suggested that both the sequence and
conformation of this portion of MSP1a influenced the
adhesive properties of the protein (de la Fuente et al.,
2003b). The results of these studies reinforced the
functional importance of the MSP1a tandem repeats in
adhesion, invasion, and transmission of A. marginale.
A. marginale MSPs are involved in interactions with
both vertebrate and invertebrate hosts (reviewed by de la
Fuente et al., 2001a; Kocan et al., 2003, 2004), and
therefore are likely to evolve more rapidly than other
nuclear genes because they are subjected to selective
pressures exerted by host immune systems. While both
msp1a and msp4 were found to be stable genetic markers
during the multiplication of a given A. marginale strain
(de la Fuente et al., 2001d; Bowie et al., 2002), they
proved to be useful in phylogenetic analysis among
geographic A. marginale strains.
Initially, we chose two A. marginale MSPs, MSP1a and
MSP4, for phylogenetic analysis and these studies
provided evidence that msp1a is under positive selection
pressure (de la Fuente et al., 2003a). Phylogenetic analysis
of A. marginale was first performed on strains from the
USA, using msp1a and msp4 genes and derived protein
sequences (de la Fuente et al., 2001d). Results of these
analyses strongly supported a southeastern clade of
A. marginale comprising Virginia and Florida isolates.
Furthermore, analysis of 16 S rDNA fragment sequences
from the tick vector of A. marginale, D. variabilis, from
various areas of the USA was performed, which suggested
co-evolution of the vector and pathogen (de la Fuente
et al., 2001d).
Subsequent phylogenetic studies of MSP1a DNA and
protein sequences from 20 New World strains of
A. marginale failed to provide phylogeographic resolu-
tion (de la Fuente et al., 2002). Most of the variations in
MSP1a sequences appeared unique for a given strain.
However, similar DNA sequence variation in MSP1a was
detected within strains from Idaho and Florida and from
Idaho and Argentina. These results suggested that MSP1a
sequences may be rapidly evolving and questioned the
use of MSP1a sequences for defining geographic strains of
A. marginale. These findings were then confirmed in
phylogenetic analyses of MSP1a DNA and protein
sequences of 13 strains from Oklahoma, in comparison
with seven Latin American and 13 strains from the USA,
which demonstrated no geographic clustering (de la
Fuente et al., 2003a). From these studies, we concluded
that MSP1a is not useful as a marker for the characteriza-
tion of geographic strains of A. marginale. The genetic
heterogeneity observed among strains of A. marginale
within Oklahoma, and within other endemic regions like
Oregon (Palmer et al., 2001), Minas Gerais in Brazil (de la
Fuente et al., 2004c), Castilla-La Mancha in Spain (de la
Fuente et al., 2004b), Kansas (Palmer et al., 2004) and
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Sicily in Italy (de la Fuente et al., 2005b) could be
explained by cattle movement and maintenance of
different genotypes by independent transmission events,
due to infection exclusion of A. marginale in cattle and
ticks which results in the establishment of only one
genotype per animal (de la Fuente et al., 2003a).
However, recent results have documented the low
frequency appearance of animals infected with two
A. marginale strains in a cattle herd with high prevalence
of infection (Palmer et al., 2004). The A. marginale msp1a
genotypes in animals infected with two strains were not
closely related and may reflect a situation similar to the
A. centrale/A. marginale co-infection reported in vacci-
nated cattle (Shkap et al., 2002b). When cattle movement
imports a new A. marginale genotype, it becomes
established and maintained by mechanical and/or bio-
logical transmission to susceptible cattle. Transmission of
A. marginale strains appears to be stochastic, at least
within a herd with a high prevalence of infection (Palmer
et al., 2004). These results predict that genotypic variation
of A. marginale strains would be minimal in regions with
few cattle/A. marginale introductions, while a highly
heterogeneous population of A. marginale genotypes
would be expected to occur in regions with extensive
cattle movement, such as Oklahoma.
Phylogenetic analysis of 55 MSP1a sequences derived
from bovine and bison in nine countries in North and
South America, Asia, Australia, and Europe (Table 1)
corroborated these predictions. A high degree of variation
was found among MSP1a sequences (Fig. 1 and Table 2).
Although MSP1a sequences failed to provide phylogeo-
graphic information, the sequences of Australian strains
clustered together (bootstrap support (bs)=94%; Fig. 2),
supporting a genetically more homogeneous A. margi-
nale population in this region with fewer cattle introduc-
tions (Lew et al., 2002). However, phylogeographic
(A) 
Repeat form Encoded sequence 
A DDSSSASGQQQESSVSSQSE-ASTSSQLG- 
B A*****G************DQ********* 
C A*****G************GQ********* 
D A****************************G 
E A***************************** 
F T******************GQ********* 
G *******************GQ******S** 
H T******************GQ******S** 
I *******************GQ********* 
J A***L*G************DQ********* 
K A*G***G************DQ********* 
L AG****D************DQ********* 
M A******************GQ********* 
m A******************GQ******S** 
N T******************DQ********* 
O ----**G************DQ********* 
P T*************G****GQ**H*A*S** 
Q A******************DQ********* 
R A*****G***H********DQ*******W* 
S A*G***G************DQ********* 
T AG****G************DQ********* 
U *******************DQ********* 
V A*****G***-********DQ********* 
W T******************GQ******SR* 
 
A*******------*L***GQ********* 
ß 
Γ
π
Σ
σ
τ
Φ
α
T*****GD***G*G*****GQ********* 
T******************D********** 
A*****G************GQ******F** 
A*****G*********************** 
A*****G******I*****DH********* 
µ A*******L**********GQ********* 
T**************L*P*GQ********* 
T***************************** 
1 SG*************L**GGQ********* 
2 T***************P**GQ********* 
3 A**************L***GQ********* 
4 T**************L***GQ********* 
5 A*********
A*********
*********D**********
6 *******H************
7 T****************H************
8 A*G***GD***********G*******S**
Fig. 1. Continued.
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(B) 
A. marginale isolate Structure of MSP1a tandem repeats No. of repeats 
Florida A B B B B B B B 8  
Idaho D D D D D E   6  
Virginia A B       2  
Washington B B B  C     4 
Wetumka, OK K C H      3  
Cushing, OK L C B C     4 
Cushing 2,OK  S N N F H    5 
Glencoe 1, OK S F N F H    5 
Glencoe 2, OK B M F H     4 
Glencoe 3, OK T B C      3 
Stillwater, OK S F F F H    5 
Stillwater 2, OK L B C C     4 
Stillwater 68, OK S B M F H    5  
Oklahoma City, OK U        1 
Okmulgee, OK S B V C     4 
Stigler, OK T B B  C     4 
Pawhuska, OK I H       2 
New Castle, OK L B C B     4 
St. Maries, ID J B B      3  
California B B C      3  
Okeechobee, FL L B C B C    5  
Mississippi D D D D E    5  
Missouri B B B B     4 
Illinois M N B M H    5  
Texas O B M P     4  
Texas 198 B B m B m    5 
South Dakota A F H      3  
Oregon A F H      3  
Kansas 3261 B B       2 
Kansas 4102 B B B      3 
Kansas 2267 B B B B     4 
Kansas 0141 B B B B B    5 
Kansas 0063 B B B B B B   6 
Kansas 5076 D D D D D    5 
Kansas 7042 D D E      3 
Kansas 4318 D D D D D E   6 
Kansas 2070 D D D D D D E  7 
Kansas 7030 D D D D D D D D D E 10 
Kansas 0050 E M       3 
Canadian bison D Q Q R     4 
U.S. bison (buffalo) K B M F W    5  
Yucatán T C B B C B π   7 
Fig. 1. Sequence of MSP1a tandem repeats in strains of A. marginale. (A) The one letter amino acid code was used to depict the
different sequences found in MSP1a repeats. Asterisks indicate identical amino acids. Gaps indicate deletions/insertions. (B)
The structure of the MSP1a repeat regions was represented for strains of A. marginale from North America (Allred et al., 1990;
Palmer et al., 2001, 2004; de la Fuente et al., 2003a, d), Latin America (de la Fuente et al., 2002, 2004c), Italy (de la Fuente
et al., 2005b), Australia (Lew et al., 2002), and Israel (Shkap et al., 2002b) using the repeat forms described in (A).
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resolution was not obtained in all the other regions of the
world analyzed, suggesting multiple introductions of A.
marginale strains from different geographic locations.
MSP2
MSP2 is an immunodominant outer membrane protein
with orthologs in all Anaplasma spp. studied thus far
(Palmer et al., 1998; Shkap et al., 2002a; Lin et al., 2004).
In A. marginale, A. centrale, and A. ovis, MSP2 is encoded
by a multigene family (Palmer et al., 1998; Shkap et al.,
2002a), while the corresponding gene in A. phagocyto-
philum is encoded by a single gene, different from the
antigenically-related p44 multigene family (Lin et al.,
2004). Cattle and ticks become persistently infected with
A. marginale and antigenic variation of MSP2 occurs
during these persistent infections (French et al., 1998,
1999; de la Fuente and Kocan, 2001). Multiple antigenic
variants arise as the result of combinatorial gene conver-
sion into a single expression site (Brayton et al., 2002).
This mechanism of antigenic variation has been suggested
to allow A. marginale to evade the bovine immune
response, thus contributing to the maintenance of
persistent infections in cattle (French et al., 1998, 1999).
Male ticks also become persistently infected with
A. marginale (Kocan et al., 1992a, b). Male ticks thus
also serve as a reservoir host and they are capable of
transmitting the pathogen to multiple hosts (reviewed by
Kocan et al., 2003, 2004). MSP2 variants appear on
A. marginale during tick feeding on multiple hosts
suggesting that antigenic variation of MSP2 in D. varia-
bilis is independent of the bovine immune response (de la
Fuente and Kocan, 2001).
Phylogenetic analysis of MSP2 sequences provided
some phylogenetic but not phylogeographic information
(Lin et al., 2004; de la Fuente et al., 2005a; Fig. 3).
The analysis of 26 MSP2 sequences of A. marginale,
A. centrale, A. ovis, and A. phagocytophilum strains,
derived from infected mammalian human and
non-human hosts in different countries (Table 1), differ-
entiated between Anaplasma species and between the
A. phagocytophilum strains, derived from ruminant and
non-ruminant hosts (Fig. 3). These findings suggest that
the function(s) of MSP2 may vary for A. phagocytophilum
and A. marginale/A. centrale/A. ovis and support the
hypothesis that A. phagocytophilum strains from rumi-
nants could share some common characteristics, includ-
ing reservoir hosts and pathogenicity, which may differ
from strains that infect humans (de la Fuente et al.,
2005a).
MSP4
MSP4, also an immunodominant outer membrane protein
with orthologs in all Anaplasma spp. examined thus far
(de la Fuente et al., 2002, 2005a, b; Molad et al., 2004), is a
highly conserved protein encoded by a single gene
(Table 2). Although the function of this protein is
unknown for any Anaplasma spp., it may be conserved
among species. Analysis of codon and amino acid
changes over the MSP4 phylogeny evidenced that msp4
is not under positive selection pressure (de la Fuente
et al., 2003a). Phylogenetic analyses using MSP4
sequences have provided phylogenetic and phylogeo-
graphic information for New World strains of A. margi-
nale with two outgroup taxa (A. centrale and A. ovis)
(de la Fuente et al., 2001d, 2002, 2003a, 2004c). When
phylogenetic analyses were conducted with 102 MSP4
sequences of A. marginale, A. centrale, A. ovis, and
A. phagocytophilum strains derived from infected
mammalian hosts and ticks in different countries (Table 1),
phylogeographic information was not obtained for A.
marginale strains, but the analysis did differentiate
between Anaplasma species (Fig. 4). These results
support those obtained with MSP1a and indicate that
MSP4 is not a good genetic marker for global phylogeo-
graphic analysis of A. marginale strains, but may still be
useful for strain comparison in some regions.
Table 2. Protein similarity range between Anaplasma strain MSPs
Pairwise comparison Similarity range (%)
MSP1a MSP2 MSP4 MSP5
A.c–A.c ND 92.7–95.2 ND ND
A.o–A.o ND 93.6–99.8 99.6–100 ND
A.p–A.p ND 89.0–99.7 91.5–100 ND
A.m–A.m 41.5–99.0 83.3–96.3 97.9–100 97.1–99.0
A.c–A.o ND 79.3–81.4 89.0–89.4 ND
A.c–A.p ND 28.9–33.1 58.5–59.2 66.8
A.c–A.m ND 74.9–83.3 88.3–89.0 91.4–92.9
A.o–A.p ND 27.7–29.0 58.2–59.6 ND
A.o–A.m ND 82.5–89.5 95.7–96.8 ND
A.p–A.m ND 25.5–28.6 56.9–59.2 64.9–65.4
Abbreviations: A.c, A. centrale; A.o, A. ovis; A.p, A. phagocytophilum; A.m, A. marginale, ND, not determined because
sequence information was not available.
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MSP5
MSP5 is an immunodominant protein encoded by a single
gene, which has been identified in A. marginale,
A. centrale, A. ovis, and A. phagocytophilum (Visser
et al., 1992; Molad et al., 2004; Dreher et al., submitted for
publication). It is a highly conserved protein (Table 2),
which, as in the case of MSP4, may have a conserved but
currently unknown function. A preliminary phylogenetic
analysis of five MSP5 sequences (Table 1) resulted in the
differentiation of Anaplasma spp. but did not allow for
the assessment of its use for phylogeographic analysis of
Anaplasma strains (Fig. 5).
Anaplasma MSPs and the immunodiagnosis
of anaplasmosis
A competitive ELISA (cELISA) has been used for the
diagnosis of Anaplasma infection in various ruminants
including cattle, ovine, and deer (Ndung’u et al., 1995;
Knowles et al., 1996; de la Fuente et al., 2004b). The
cELISA currently used for the diagnosis of bovine
anaplasmosis, developed by Knowles et al. (1996), is
based on the use of the monoclonal antibody (Mab)
ANAF16C1 that recognizes MSP5 in A. marginale,
A. centrale, and A. ovis (Visser et al., 1992). However,
recent findings suggest that this MSP5 ELISA, currently
commercialized by VMRD, Inc. (Pullman, WA, USA), may
also recognize A. phagocytophilum antibodies in infected
cattle (Dreher et al., submitted for publication). The
MSP5 sequence is highly conserved and thus similar
among strains of A. marginale, as well as between A.
marginale, A. centrale, and A. phagocytophilum (Table 2).
The cross-reactivity of the MSP5 test with multiple species
of Anaplasma has been confirmed through the identifica-
tion of common regions defined to be essential for
ANAF16C1 reactivity (Munodzana et al., 1998). Thus, the
MSP5 cELISA does not differentiate Anaplasma species in
regions where co-infection with A. phagocytophylum and
A. marginale or A. centrale occurs (de la Fuente et al.,
2004a; Hofmann-Lehmann et al., 2004; Lin et al., 2004).
Although a second test specific for A. phagocytophilum
(for example the immunofluorescence HGE IFA Antibody
Test Kit; Fuller Laboratories, Fullerton, CA, USA) or A.
centrale (Molloy et al., 2001) may be used, the possibility
of cross-infection cannot be ruled out when using these
assays in these regions. An ELISA based on recombinant
MSP5 for indirect A. marginale antibody detection was
developed by Morzaria et al. (1999) and is commercia-
lized by Svanova Biotech AB (Uppsala, Sweden) but the
assay has not been evaluated for cross-reactivity with
other Anaplasma species. However, it should be possible
to explore the possibility of developing serological tests
for the differential detection of Anaplasma infections
based on the non-conserved MSP5 regions.
Fig. 2. Phylogenetic analysis using Mega 2 of A. marginale
strains based on the MSP1a protein sequences using the NJ
algorithm with Poisson correction and bootstrap analysis of
1000 replicates. Numbers on the branches indicate percent
support for each clade. Strains were coded according to the
country of origin to emphasize the geographic distribution of
the strains. Sequence information was derived from the
references in Fig. 1 legend.
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Although DNA-based diagnostic methods could be
used to identify the pathogen species of Anaplasma
infections, a serologic test based on MSPs would be more
practical for the diagnosis of large number of animals.
MSP4, which is also highly conserved among Anaplasma
spp. (Table 2), would probably give cross-reactive results
similar to those obtained with MSP5. According to
sequence similarity, the conserved regions of MSP2 may
prove useful to discriminate between A. phagocytophilum
and the other Anaplasma spp. (Table 2), but panels of
Mabs would have to be generated and characterized to
develop a serological test based on MSP2. Recombinant
antigens, such as the A. phagocytophilum MSP2-related
p44, may be used to detect antibodies in infected hosts
(Magnarelli et al., 2004). MSP1a, although highly variable
in the extracellular region between geographic strains of
A. marginale, could be used to identify infections caused
by A. marginale because it may prove to be specific for
this species. A neutralization epitope, which is conserved
among strains of A. marginale (Garcia-Garcia et al.,
2004b), was identified in the repeat regions of MSP1a
(Palmer et al., 1987). Our group has recently
demonstrated that Mabs generated against conserved
epitopes in the variable extracellular region of MSP1a
were able to recognize geographically distinct strains of
A. marginale (unpublished results).
Anaplasma MSPs and the development of vaccines
for the control of anaplasmosis
The pioneering work of Tebele et al. (1991) demonstrated
that immunization with A. marginale outer membranes
induced immunity against clinical disease which corre-
lated with antibody titer to MSPs. Since then, extensive
research has been devoted to the identification and
testing of A. marginale MSPs for their ability to induce a
protective immune response in cattle (reviewed by Kocan
et al., 2003).
Recent research, as reviewed by Palmer (1989) and
Palmer et al. (1999), has provided much information on
the nature of the immune response of cattle to
A. marginale infection, as well as the identification of
key A. marginale antigens that appear to play a role in the
Fig. 3. Phylogenetic analysis using Mega 2 of Anaplasma species based on the MSP2 protein sequences using the NJ algorithm
with Poisson correction and bootstrap analysis of 1000 replicates. Numbers on the branches indicate percent support for each
clade. Sequence GenBank accession numbers are shown in parenthesis. Abbreviations: A.c, A. centrale; A.o, A. ovis; A.p, A.
phagocytophilum; A.m, A. marginale; V, variant; ID, Idaho, USA; VA, Virginia, USA; FL, Florida, USA; ISR, Israel; CH,
Switzerland. The A. phagocytophilum HZ genome sequence database is located at www.tigr.org.
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immune response. A model for vaccine-induced immu-
nity against A. marginale was proposed in which
pathogen clearance is affected by antibodies against
surface epitopes in combination with macrophage activa-
tion for enhanced phagocytosis and killing. The center-
piece of this model is the CD4+ T lymphocyte expressing
INF-g which enhances synthesis of the predominant
opsonizing bovine IgG subclass, IgG2, and concomitantly
activates macrophages to increase receptor expression,
phagocytosis, phagolysomosal fusion, and release of
rickettsiacidal nitric oxide. Brown et al. (1998a) demon-
strated that induction of these responses using purified
outer membrane proteins prevented A. marginale rick-
ettsemia upon challenge-exposure. CD4+ T lymphocyte
clones from protectively immunized cattle were found to
be diverse and several clones responded to MSP1a and
MSP2 (Brown et al., 1998b, 2001a, b, 2002, 2003, 2004).
Furthermore, recent results have indicated that WC1(+)
gamma delta T cells recognize A. marginale MSP2
through the T cell receptor and may contribute to the
immunodominant response to this protein (Lahmers et al.,
2005). However, in a recent study, thymectomized calves
were able to control acute anaplasmosis after their CD4+
T lymphocytes were selectively depleted by treatment
with an anti-CD4 Mab (Valdez et al., 2002). Therefore,
although CD4+ T lymphocytes may play a role in
controlling A. marginale infection, the antibody response
appears to be essential.
Limited vaccine trials have been conducted using
recombinant MSPs (as reviewed by Kocan et al., 2003),
recombinant vaccinia virus expressing A. marginale
antigens (McGuire et al., 1994) or with naked DNA
(Arulkanthan et al., 1999). Thus far, only partial protec-
tion has been obtained with recombinant antigens used
for vaccination, suggesting that a vaccine containing
multiple antigens will probably be required to induce a
protective immune response. From vaccination trials and
in vitro studies, MSP1a and MSP2 have provided the most
encouraging results. The A. marginale MSP2, although
capable of inducing a strong T cell response (Brown
et al., 1998b, 2001a, 2003, 2004; Abbott et al., 2004), is
antigenically variable in persistently infected cattle, which
may reduce the effectiveness of this MSP for use in a
Fig. 4. Phylogenetic analysis using Mega 2 of Anaplasma
species based on the MSP4 protein sequences using the NJ
algorithm with Poisson correction and bootstrap analysis of
1000 replicates. Numbers on the branches indicate percent
support for each clade (>60%). Sequence GenBank
accession numbers are shown in parenthesis for A. phago-
cytophilum, A. ovis, and A. centrale. Strains of A. marginale
were not indicated to simplify the tree. Sequences for A.
marginale MSP4 were derived from de la Fuente et al.
(2001a, d, 2002, 2003a, d, 2004b, c, 2005a, b) or from
unpublished results (Israeli strains, AY786993, AY786994,
AY787172; Italian strains from Apulia and Calabria regions,
AY829458–AY829460; Swiss strains, AY851150; Australian
strains, AY665997–AY666003; South African strain,
AY666005; Kenyan strain, AY666004; Zimbabwean strains,
AY666006–AY666011). Abbreviations: A.c, A. centrale; A.o,
A. ovis; A.p, A. phagocytophilum; A.m, A. marginale; IT,
Italy; ID, Idaho; WI, Wisconsin; ISR, Israel; Ge, Germany; Po,
Poland; No, Norway; CH, Switzerland; SP, Spain; V, variant;
O, ovine; Bo, bovine; H, human.
 A.m FL (A49213) 
 A.m BR (AAO92930)
 A.m HAV (AAS18265)
 A.c ISR (AAL17671) 
 A.p HZ (TIGR contig : 513)
100
56
0.05 
Fig. 5. Phylogenetic analysis using Mega 2 of Anaplasma species based on the MSP5 protein sequence using the NJ algorithm
with Poisson correction and bootstrap analysis of 1000 replicates. Numbers on the branches indicate percent support for each
clade. Sequence GenBank accession numbers are shown in parenthesis. Abbreviations: A.c, A. centrale; A.p,
A. phagocytophilum; A.m, A. marginale, FL, Florida, USA; BR, Brazil; ISR, Israel, HAV, Havana, Cuba. The A.
phagocytophilum HZ genome sequence database is located at www.tigr.org.
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vaccine formulation. MSP2 antigenically variable B-cell
epitopes are concentrated in the hypervariable region and
are recognized by the immune system of A. marginale-
infected cattle (Abbott et al., 2004), which results in the
selection of new variants that may allow the pathogen to
establish persistent infections (French et al., 1998, 1999).
Therefore, the effect of the antibody responses against
MSP2 most likely would not be neutralizing. Nevertheless,
engineered synthetic polypeptides containing MSP2
conserved regions could be evaluated as candidate
immunogens.
MSP1a, on the other hand, although variable in the
number of repeated peptides, induces strong T cell
responses (Brown et al., 2001b, 2002) and contains
conserved B cell epitopes in the repeated peptides that
are recognized by immunized and protected cattle
(Garcia-Garcia et al., 2004b). These results, together with
the biological significance of MSP1a function in infection
and transmission of A. marginale, suggest that MSP1a
may be a good candidate for inclusion in vaccines for the
control of bovine anaplasmosis. Experiments conducted
to evaluate the protection capacity of recombinant MSP1a
alone or in combination with whole A. marginale
antigens from infected cultured tick IDE8 cells demon-
strated that a preferential antibody response to MSP1a
correlates with lower percent reductions in packed cell
volume (PCV) and thus reduced clinical disease (Garcia-
Garcia et al., 2004b). Although cattle infected with A.
marginale mount an immune response against MSP1a, it
is likely directed to the MSP1 complex in which MSP1a is
covalently linked to MSP1b, perhaps masking some of the
MSP1a protective epitopes otherwise exposed in the
recombinant antigen. This hypothesis is further supported
by the finding that immunization of cattle with A.
marginale derived from infected erythrocytes in which
MSP1a is upregulated with respect to MSP1b and
probably exists uncoupled to MSP1b, provided a level
of protection comparable to that observed in cattle
immunized with recombinant MSP1a and A. marginale
derived from infected tick cells, in which MSP1a is
downregulated and most likely exists only in the MSP1
complex with MSP1b (Garcia-Garcia et al., 2004b).
Another factor to be considered for the induction of a
protective immune response against A. marginale is the
role of sugar moieties of MSP1a in the protection
properties, which may also contribute to the generation
of a neutralizing response in cattle (Garcia-Garcia et al.,
2004a).
A. centrale, isolated by Sir Arnold Theiler in the early
1900s, is the most widely used live vaccine strain for
control of bovine anaplasmosis (Theiler, 1911). This
A. centrale strain continues to be used for vaccine
production in several areas of the world including Africa,
Australia, Israel, and South America (reviewed by Bock
et al., 2003; Kocan et al., 2003). As discussed above,
MSP1a has not been identified in A. centrale despite
multiple attempts for its cloning. However, although a
protein functionally similar to MSP1a may still exist in
A. centrale, this result suggests that differences may exist
in the mechanism of protection elicited by A. centrale and
A. marginale. Nevertheless, both A. centrale and
A. marginale share immunodominant epitopes that may
play a role in the protection induced by A. centrale
(Shkap et al., 1991, 2002a, b). Bock et al. (2003) described
the use of a mild strain of A. marginale as an alternative to
the A. centrale vaccine but its efficacy has not been
demonstrated yet.
Recently, A. marginale proteins with molecular weights
ranging from 17 to 43 kDa have been identified for their
capacity to induce a protective response in cattle through
the induction of IgG2 responses (Riding et al., 2003;
Barigye et al., 2004; Hope et al., 2004). These antigens,
predicted to be integral membrane proteins, may prove to
be new candidate MSPs for vaccination against bovine
anaplasmosis.
Recombinant MSPs from other Anaplasma species
have not been used for vaccination. However, it would
be interesting to evaluate vaccine formulations contain-
ing other recombinant Anaplasma MSPs such as the
A. phagocytophilum MSP2.
Conclusions
Anaplasma spp. MSPs interact with host cells during
infection and transmission of the pathogen. Concurrent
infections with different Anaplasma species may intro-
duce new considerations for the diagnosis and control of
anaplasmosis. Sequence similarity in MSP5 sequences
among Anaplasma spp. may result in a reduced ability to
make a differential diagnosis based on existing serological
assays in infected animals and prompts the development
of alternative diagnostic methods. Genetic diversity in
MSPs suggests that multiple introductions of diverse
strains of A. marginale have occurred in most geographic
areas, an important consideration when designing and
evaluating vaccine formulations for the control of bovine
anaplasmosis.
The ideal vaccine for anaplasmosis would be the one
that induces protective immunity and prevents infection
and transmission of the pathogen. Current vaccines do
not prevent infection and persistently infected cattle are a
major reservoir of A. marginale, thus serving as a source
of infection for mechanical and biological transmission by
ticks. Although transmission-blocking antigens have not
been identified from the tick vector or the pathogen,
recent results suggest that antibodies to recombinant
MSP1a may reduce infectivity for D. variabilis (de la
Fuente et al., 2003c), in accordance with results obtained
in neutralization studies in vitro (Blouin et al., 2002,
2003). However, further research is needed to fully
understand the developmental cycle of A. marginale in
cattle and ticks in order to design a vaccine that will
prevent infection of both hosts.
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The full genome sequences of A. marginale and
A. phagocytophilum are complete (Brayton et al., 2005)
or close to completion and should be released in early
2005 (A. phagocytophilum and A. marginale genome
sequence databases are located at www.tigr.org and
www.vetmed.wsu.edu/research%5Fvmp/anagenome/,
respectively). This information will prove to be essential
for global comparative studies of Anaplasma strains,
which should add considerable information on the
genetic diversity of Anaplasma MSPs. Genome sequences
can be also used for in silico search and biological
throughput screening of polypeptides with potential
value for diagnosis and vaccine development.
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